EUR 162.78
(-1.01%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 6.75 Billion USD | 0.21% |
2022 | 6.73 Billion USD | -0.07% |
2021 | 6.74 Billion USD | -0.22% |
2020 | 6.75 Billion USD | 10.59% |
2019 | 6.11 Billion USD | -5.15% |
2018 | 6.44 Billion USD | 30.08% |
2017 | 4.95 Billion USD | 10.85% |
2016 | 4.46 Billion USD | 0.11% |
2015 | 4.46 Billion USD | 22.51% |
2014 | 3.64 Billion USD | 0.03% |
2013 | 3.64 Billion USD | 615.52% |
2012 | 509 Million USD | -11.48% |
2011 | 575 Million USD | -14.56% |
2010 | 673 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 6.74 Billion USD | 0.03% |
2024 Q2 | 6.74 Billion USD | 0.02% |
2023 Q4 | 6.75 Billion USD | 0.13% |
2023 Q1 | 6.73 Billion USD | 0.01% |
2023 FY | 6.75 Billion USD | 0.21% |
2023 Q3 | 6.74 Billion USD | 0.0% |
2023 Q2 | 6.74 Billion USD | 0.06% |
2022 Q4 | 6.73 Billion USD | 24.87% |
2022 Q3 | 5.39 Billion USD | 0.26% |
2022 Q1 | 5.38 Billion USD | -20.12% |
2022 FY | 6.73 Billion USD | -0.07% |
2022 Q2 | 5.38 Billion USD | -0.07% |
2021 Q1 | 6.74 Billion USD | -0.18% |
2021 Q2 | 6.73 Billion USD | -0.1% |
2021 Q3 | 6.75 Billion USD | 0.19% |
2021 Q4 | 6.74 Billion USD | -0.13% |
2021 FY | 6.74 Billion USD | -0.22% |
2020 Q2 | 7.34 Billion USD | 20.04% |
2020 Q3 | 6.76 Billion USD | -7.99% |
2020 Q4 | 6.75 Billion USD | -0.06% |
2020 FY | 6.75 Billion USD | 10.59% |
2020 Q1 | 6.12 Billion USD | 0.18% |
2019 Q3 | 6.61 Billion USD | 0.02% |
2019 FY | 6.11 Billion USD | -5.15% |
2019 Q4 | 6.11 Billion USD | -7.63% |
2019 Q1 | 6.57 Billion USD | 2.1% |
2019 Q2 | 6.61 Billion USD | 0.56% |
2018 Q3 | 6.44 Billion USD | 29.99% |
2018 FY | 6.44 Billion USD | 30.08% |
2018 Q4 | 6.44 Billion USD | 0.03% |
2018 Q2 | 4.95 Billion USD | 0.02% |
2018 Q1 | 4.95 Billion USD | 0.02% |
2017 Q1 | 3.71 Billion USD | -16.79% |
2017 Q2 | 3.71 Billion USD | 0.03% |
2017 Q3 | 4.95 Billion USD | 33.15% |
2017 Q4 | 4.95 Billion USD | 0.02% |
2017 FY | 4.95 Billion USD | 10.85% |
2016 Q1 | 4.46 Billion USD | 0.02% |
2016 Q2 | 4.46 Billion USD | 0.02% |
2016 Q3 | 4.46 Billion USD | 0.04% |
2016 FY | 4.46 Billion USD | 0.11% |
2016 Q4 | 4.46 Billion USD | 0.02% |
2015 FY | 4.46 Billion USD | 22.51% |
2015 Q4 | 4.46 Billion USD | 38.34% |
2015 Q2 | 3.24 Billion USD | 0.0% |
2015 Q1 | 3.24 Billion USD | -10.98% |
2015 Q3 | 3.22 Billion USD | -0.52% |
2014 Q4 | 3.64 Billion USD | 0.03% |
2014 Q1 | 3.64 Billion USD | 0.0% |
2014 Q2 | 3.64 Billion USD | 0.0% |
2014 FY | 3.64 Billion USD | 0.03% |
2014 Q3 | 3.64 Billion USD | 0.0% |
2013 Q1 | 3.64 Billion USD | 615.13% |
2013 FY | 3.64 Billion USD | 615.52% |
2013 Q4 | 3.64 Billion USD | 0.0% |
2013 Q3 | 3.64 Billion USD | 0.05% |
2013 Q2 | 3.64 Billion USD | 0.0% |
2012 Q4 | 509 Million USD | -12.24% |
2012 Q3 | 580 Million USD | 1.22% |
2012 FY | 509 Million USD | -11.48% |
2012 Q1 | 579 Million USD | 0.7% |
2012 Q2 | 573 Million USD | -1.04% |
2011 Q4 | 575 Million USD | 0.0% |
2011 FY | 575 Million USD | -14.56% |
2010 FY | 673 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
MPH Health Care AG | 8.33 Million EUR | -80924.003% |
Apontis Pharma AG | 6 Million EUR | -112433.333% |
Dermapharm Holding SE | 950.7 Million EUR | -610.21% |
Evotec SE | 477.11 Million EUR | -1315.181% |
MERCK Kommanditgesellschaft auf Aktien | 8.84 Billion EUR | 23.672% |
PharmaSGP Holding SE | 65.37 Million EUR | -10228.897% |
SynBiotic SE | 2.89 Million EUR | -233255.049% |